Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER) II

In patients with acute cancer-associated thrombosis, current consensus guidelines recommend anticoagulation therapy for an indefinite duration or until the cancer is resolved. Among 1,247 patients with acute venous thromboembolism (VTE) enrolled in the prospective Swiss Venous Thromboembolism Regist...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thrombosis and haemostasis 2011-06, Vol.105 (6), p.962-967
Hauptverfasser:	SPIRK, David, UGI, Jörg, KUCHER, Nils, KORTE, Wolfgang, HUSMANN, Marc, HAYOZ, Daniel, BALDI, Thomas, FRAUCHIGER, Beat, BANYAI, Martin, AUJESKY, Drahomir, BAUMGARTNER, Iris
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adult Aged Aged, 80 and over Anticoagulants - administration & dosage Anticoagulants - adverse effects Biological and medical sciences Blood coagulation. Blood cells Clinical Protocols Disease Progression Fundamental and applied biological sciences. Psychology Hematologic and hematopoietic diseases Heparin, Low-Molecular-Weight - administration & dosage Heparin, Low-Molecular-Weight - adverse effects Humans Medical sciences Molecular and cellular biology Neoplasm Metastasis Neoplasms - complications Neoplasms - drug therapy Neoplasms - physiopathology Neoplasms - surgery Platelet diseases and coagulopathies Recurrence Switzerland Time Factors Venous Thromboembolism - drug therapy Venous Thromboembolism - etiology Venous Thromboembolism - physiopathology Venous Thromboembolism - surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In patients with acute cancer-associated thrombosis, current consensus guidelines recommend anticoagulation therapy for an indefinite duration or until the cancer is resolved. Among 1,247 patients with acute venous thromboembolism (VTE) enrolled in the prospective Swiss Venous Thromboembolism Registry (SWIVTER) II from 18 hospitals, 315 (25%) had cancer of whom 179 (57%) had metastatic disease, 159 (50%) ongoing or recent chemotherapy, 83 (26%) prior cancer surgery, and 63 (20%) recurrent VTE. Long-term anticoagulation treatment for >12 months was more often planned in patients with versus without cancer (47% vs. 19%; p
ISSN:	0340-6245 2567-689X
DOI:	10.1160/TH11-01-0002